The anticonvulsant and proconvulsant effects of α₂-ADRENORECEPTOR agonists are mediated by distinct populations of α_2A-ADRENORECEPTORSSZOT, P; LESTER, M; LAUGHLIN, M. L et al.Neuroscience. 2004, Vol 126, Num 3, pp 795-803, issn 0306-4522, 9 p.Article

Control of antigen presentation with a photoreleasable agonist peptideDEMOND, Andrew L; STARR, Toby; DUSTIN, Michael L et al.Journal of the American Chemical Society. 2006, Vol 128, Num 48, pp 15354-15355, issn 0002-7863, 2 p.Article

Simple method for evaluation of stimulatory effect of drugs on presynaptic dopamine receptors in miceWATANABE, H.Journal of pharmacological methods. 1985, Vol 14, Num 1, pp 41-47, issn 0160-5402Article

GLUCOCORTICOID HEDGEHOG AGONISTS IN NEUROGENESISJIANGBO WANG; BARAK, Larry S; MOOK, Robert A et al.Vitamins and hormones. 2011, Vol 87, pp 207-215, issn 0083-6729, 9 p.Article

Differential behavioral effect of the TRPM8/TRPA channel agonist icilin (AG-3-5)RAWLS, Scott M; GOMEZ, Teresa; ZHE DING et al.European journal of pharmacology. 2007, Vol 575, Num 1-3, pp 103-104, issn 0014-2999, 2 p.Article

Production of paradoxical sensory hypersensitivity by α₂-Adrenoreceptor agonistsQUARTILHO, Aline; MATA, Heriberto P; IBRAHIM, Mohab M et al.Anesthesiology (Philadelphia). 2004, Vol 100, Num 6, pp 1538-1544, issn 0003-3022, 7 p.Article

Inverse agonist activity of agouti and agouti-related proteinCHAI, Biao-Xin; NEUBIG, Richard R; MILLHAUSER, Glenn L et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 4, pp 603-609, issn 0196-9781, 7 p.Article

Direct agonist/antagonist functions of dehydroepiandrosteroneFANG CHEN; KNECHT, Kristin; RESZKA, Alfred A et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 11, pp 4568-4576, issn 0013-7227, 9 p.Article

Opioid analgesics : Comparative features and prescribing guidelinesCHERNY, N. I.Drugs (Basel). 1996, Vol 51, Num 5, pp 713-737, issn 0012-6667Article

Design and synthesis of azabicyclic muscarinic agonists incorporating an oxime ether functionalityBROMIDGE, S. M; BROWN, F; CASSIDY, F et al.Cholinomimetics and Alzheimer's disease. Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 8, pp 787-790Book Chapter

Affinities of muscarinic drugs for [³H]N-methylscopolamine (NMS) and [³H]oxotremorine (OXO) binding to a mixture of M₁-M₄ muscarinic receptors : use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classesSHARIF, N. A; WILLIAMS, G. W; DESANTIS, L. M et al.Neurochemical research. 1995, Vol 20, Num 6, pp 669-674, issn 0364-3190Article

Partial agonists, full agonists, antagonists : dilemmas of definitionHOYER, D; BODDEKE, H. W. G. M.Trends in pharmacological sciences (Regular ed.). 1993, Vol 14, Num 7, pp 270-275, issn 0165-6147Article

Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogueLABARRE, Maryse; BUTTERWORTH, Joanne; ST-ONGE, Stephane et al.European journal of pharmacology. 2000, Vol 406, Num 1, pp R1-R3, issn 0014-2999Article

The TRβ-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronineVENDITTI, P; CHIELLINI, G; DI STEFANO, L et al.Journal of endocrinology. 2010, Vol 205, Num 3, pp 279-289, issn 0022-0795, 11 p.Article

Thiazolidinediones Are Partial Agonists for the Glucocorticoid ReceptorMATTHEWS, L; BERRY, A; TERSIGNI, M et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 1, pp 75-86, issn 0013-7227, 12 p.Article

Influence du muscimol (GABA-agoniste) sur une boucle de régulation thalamo-hypothalamique à efférence corticotrope (modèle thalamique) = Influence of muscimol (GABA-agonist) on thalamo-hypothalamic regulation loop with corticotropic efference (thalamic model)RAMADE, F; BAYLE, J. D.Comptes rendus des séances de la Société de biologie et de ses filiales. 1985, Vol 179, Num 3, pp 383-388, issn 0037-9026Article

The Melanocortin Agonist AP214 Exerts Anti-Inflammatory and Proresolving PropertiesMONTERO-MELENDEZ, Trinidad; PATEL, Hetal B; SEED, Michael et al.The American journal of pathology. 2011, Vol 179, Num 1, pp 259-269, issn 0002-9440, 11 p.Article

Eltrombopag : An effective remedy for thrombocytopaenia?MONDELLI, Mario U.Journal of hepatology. 2008, Vol 48, Num 6, pp 1030-1032, issn 0168-8278, 3 p.Article

Corepressors of agonist-bound nuclear receptorsGUREVICH, Igor; FLORES, Anthony M; ANESKIEVICH, Brian J et al.Toxicology and applied pharmacology. 2007, Vol 223, Num 3, pp 288-298, issn 0041-008X, 11 p.Article

Proof-of-concept trial of an α7 nicotinic agonist in schizophreniaOLINCY, Ann; HARRIS, Josette G; STEVENS, James O et al.Archives of general psychiatry. 2006, Vol 63, Num 6, pp 630-638, issn 0003-990X, 9 p.Article

Amylin agonists: A novel approach in the treatment of diabetesSCHMITZ, Ole; BROCK, Birgitte; RUNGBY, Jorgen et al.Diabetes (New York, NY). 2004, Vol 53, pp S233-S238, issn 0012-1797, SUP3Conference Paper

GABA agonists and antagonistsKERR, D. I. B; ONG, J.Medicinal research reviews (Print). 1992, Vol 12, Num 6, pp 593-636, issn 0198-6325Article

A new dopamine agonist in dopamine deprived systems : FCE 23884BUONAMICI, M; CERVINI, M. A; MAJ, R et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 179S-183S, issn 0197-0186, SUPConference Paper

Agonists and antagonists of 5-HT₃ receptorsFOZARD, J. R.Developments in cardiovascular medicine. 1990, Vol 106, pp 101-115, issn 0166-9842Article

Vasopressin agonists and antagonistsTHIBONNIER, M.Hormone research. 1990, Vol 34, Num 3-4, pp 124-128, issn 0301-0163, 5 p.Conference Paper